Top Story

Boehringer Ingelheim files BLA for antidote to dabigatran

March 2, 2015

Boehringer Ingelheim announced that it has submitted a biologics license application to the FDA requesting an accelerated approval pathway for idarucizumab, an antidote to dabigatran.

In June 2014, the investigational reversal agent received a breakthrough therapy designation from the FDA.

Sylvia Burwell

HHS recognizes public, private practices as Hypertension Control Champions

March 1, 2015
The US Department of Health and Human Services’ Million Hearts initiative recognizes 30 U.S. public and private health care practices and systems as Hypertension…
thumbnail for video 4083453350001 Meeting News CoverageVideo

Video: Action needed to reduce CVD risks in HIV patients

February 28, 2015
SEATTLE — Steven Grinspoon, MD, of the Massachusetts General Hospital and Harvard Medical School, gives an overview of his CROI 2015 plenary session discussing…
Lee Schwamm

AHA/ASA announce collaboration to reduce cryptogenic stroke in US

February 28, 2015
The American Heart Association, American Stroke Association and Medtronic recently announced a collaboration to reduce the rate of recurrent cryptogenic strokes in the…
In the Journals

Intense anger, anxiety increase short-term MI risk

February 27, 2015
Patients who experienced intense episodes of anger or anxiety had a significantly increased risk for acute coronary occlusion within the subsequent 2 hours, according to…
More News Headlines »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
Meeting News Coverage Video
Healio ISC2015 Singhal th

VIDEO: Intra-arterial thrombectomy trial results indicate 'formula for success'

February 25, 2015
NASHVILLE, Tenn. — Aneesh B. Singhal, MD, vice chair of quality and safety at Massachusetts General Hospital…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
morganatic-roan